Back

Household transmission of SARS-CoV-2 during the Omicron wave in Shanghai, China: a case-ascertained study

Wei, Z.; Ma, W.; Wang, Z.; Li, J.; Fu, X.; Chang, H.; Qiu, Y.; Tian, H.; Ge, Y.; Zhu, Y.; Xia, A.; Wu, Q.; Liu, G.; Zhai, X.; Zhang, X.; Wang, Y.; Zeng, M.

2022-09-27 infectious diseases
10.1101/2022.09.26.22280362 medRxiv
Show abstract

BackgroundSince late 2021, the highly transmissible SARS-CoV-2 Omicron variant has driven a new surge of infections across the world. We used a case-ascertained study to determine the features of household transmission of SARS-CoV-2 Omicron variant in Shanghai, China. MethodsWe collected detailed information on 323 pediatric cases and their 951 household members in April 2022 during the Omicron outbreak. All household members received consecutively intensive RT-PCR testing for SARS-CoV-2 and routine symptom monitoring within 14 days after exposure to a confirmed case. We described the characteristics of study participants and estimated the transmission parameters. Both secondary infection attack rates (SARI) and secondary clinical attack rates (SARC) among adult household contacts were computed, through which the transmission heterogeneities in infectivity and susceptibility were characterized and the vaccine effectiveness were estimated. ResultsWe estimated the mean incubation period of SARS-CoV-2 Omicron variant to be 4.6 (median: 4.4, IQR: 3.1-6.0) days and the mean serial interval to be 3.9 (median:4.0, IQR: 1.4-6.5) days. The overall SARI and SARC among adult household contacts were 77.11% (95% confidence interval [CI]: 73.58%-80.63%) and 67.03% (63.09%-70.98%). We found higher household susceptibility in females, while infectivity was not significantly different in primary cases by age, sex, vaccination status and clinical severity. The estimated VEs of full vaccination was 14.8% (95% CI: 5.8%-22.9%) against Omicron infection and 21.5% (95% CI: 10.4%-31.2%) against symptomatic disease. The booster vaccination was 18.9% (95% CI: 9.0%-27.7%) and 24.3% (95% CI: 12.3%-34.7%) effective against infection and symptomatic disease, respectively. ConclusionsWe found high household transmission during the Omicron wave in Shanghai due to asymptomatic and pre-symptomatic transmission in the context of city-wide lockdown, indicating the importance of early detection and timely isolation of SARS-CoV-2 infections and quarantine of close contacts. Marginal effectiveness of inactivated vaccines against Omicron infection poses great challenge for prevention and control of the SARS-CoV-2 Omicron variant.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

1
The Lancet Infectious Diseases
71 papers in training set
Top 0.1%
22.9%
2
Clinical Infectious Diseases
231 papers in training set
Top 0.3%
10.3%
3
Eurosurveillance
80 papers in training set
Top 0.1%
7.3%
4
Nature Communications
4913 papers in training set
Top 32%
4.9%
5
PLOS Medicine
98 papers in training set
Top 0.7%
4.4%
6
Emerging Infectious Diseases
103 papers in training set
Top 0.4%
4.2%
50% of probability mass above
7
The Lancet Regional Health - Western Pacific
15 papers in training set
Top 0.1%
4.0%
8
Journal of Infection
71 papers in training set
Top 0.3%
4.0%
9
International Journal of Infectious Diseases
126 papers in training set
Top 0.4%
4.0%
10
BMC Medicine
163 papers in training set
Top 2%
2.8%
11
BMC Public Health
147 papers in training set
Top 3%
2.1%
12
The Journal of Infectious Diseases
182 papers in training set
Top 2%
2.1%
13
Frontiers in Medicine
113 papers in training set
Top 4%
1.5%
14
Emerging Microbes & Infections
74 papers in training set
Top 0.9%
1.5%
15
BMC Infectious Diseases
118 papers in training set
Top 3%
1.5%
16
eClinicalMedicine
55 papers in training set
Top 0.8%
1.4%
17
Influenza and Other Respiratory Viruses
44 papers in training set
Top 0.3%
1.2%
18
Clinical Microbiology and Infection
60 papers in training set
Top 0.9%
1.1%
19
Open Forum Infectious Diseases
134 papers in training set
Top 2%
1.0%
20
Annals of Internal Medicine
27 papers in training set
Top 0.7%
0.9%
21
The Lancet Regional Health - Europe
32 papers in training set
Top 0.3%
0.9%
22
Journal of Medical Virology
137 papers in training set
Top 4%
0.8%
23
American Journal of Epidemiology
57 papers in training set
Top 1%
0.8%
24
The Lancet Public Health
20 papers in training set
Top 0.6%
0.8%
25
New England Journal of Medicine
50 papers in training set
Top 0.8%
0.8%
26
Cell Research
49 papers in training set
Top 3%
0.7%
27
JAMA
17 papers in training set
Top 0.4%
0.7%
28
Medicine
30 papers in training set
Top 3%
0.7%
29
The Lancet
16 papers in training set
Top 0.9%
0.7%
30
mSphere
281 papers in training set
Top 7%
0.7%